Definitive Contract 75N91018C00005
Award Date 6/4/18
Potential Completion Date 6/3/28
Potential Value $30M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60637, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a definitive contract to Westat, Inc. for support services for integrative epidemiological studies on September 22, 2018, with a ceiling value of $16.48 million and ultimate completion date of March 21, 2024. The contract is priced cost-plus-fixed-fee with no set-aside. Place of performance is Rockville, Maryland. Service Contract Inventory reporting shows the contract invoiced $11.42 million across FY2018–FY2024, with labor activity peaking in FY2023 at...
- The National Cancer Institute issued a delivery order to North American Association of Central Cancer Registries Inc. on July 1, 2021, with a ceiling value of $7,011,419 under its single-award IDIQ for support services developing and promoting methods and standards for cancer registry operations and surveillance data. The order is exercising an option extending the period of performance through August 31, 2026, with FY26 funds obligated. Place of performance is Springfield, IL. The order is...
- The National Cancer Institute issued a delivery order to Kaiser Foundation Hospitals on July 25, 2020, under the Cancer Study Cohort Recruitment parent IDIQ for study preparation and launch activities, with a ceiling value of $20.6 million. Place of performance is Aurora, Colorado. The order carries Cost No Fee pricing and ultimate completion date of August 9, 2025. Service Contract Inventory data shows the order has grown in labor footprint and invoicing. In FY2024, the most recent reported...
- The National Cancer Institute issued a delivery order to North American Association of Central Cancer Registries Inc. (NAACCR) on September 19, 2021, with a ceiling value of $1,695,403, under its $16 million single-award IDIQ contract for support services developing and promoting methods and standards for cancer registry operations. The order exercises FAR 52.217-8 to extend the period of performance through August 31, 2026, and obligates FY26 funds. Place of performance is Springfield, IL....
- The National Cancer Institute issued a delivery order to the North American Association of Central Cancer Registries Inc. (NAACCR) on July 1, 2015, with a ceiling value of $4,929,900.59 for technical support for cancer surveillance. The order operates under cost-plus-fixed-fee pricing and carries an ultimate completion date of June 30, 2021. Place of performance is Springfield, IL. NAACCR, a tax-exempt nonprofit, self-performed all labor under this delivery order with no subcontractor...
- The National Cancer Institute awarded a $30.2 million cost-plus-fixed-fee definitive contract to Asrc Federal Technology Solutions, LLC for central support to the National Cancer Institute Center for Cancer Research on January 15, 2023, under a competitive 8(a) set-aside. The contract is an Alaska Native Corporation-owned, SBA 8(a) certified small disadvantaged business. Place of performance is Bethesda, MD. The originating solicitation, posted August 10, 2022, sought comprehensive quality...
- The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on July 8, 2016, with a ceiling value of $375,000 for analysis and recommendations on strategic management of the National Cancer Institute's National Clinical Trials Network (NCTN). Place of performance is Alexandria, VA. The period of performance runs from July 11, 2016, through July 10, 2021. The order is priced as cost plus fixed fee. During fiscal year 2021, the most recent reported period, the order...
- The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on September 15, 2014, for implementation of the NCI Community Oncology Research Program (NCORP), with a ceiling value of $435,969.83. This is a cost-plus-fixed-fee delivery order with no set-aside. The period of performance extends through August 30, 2018, following a no-cost extension that added two months to the original timeline. Place of performance is Alexandria, VA. The total funded amount...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 25, 2020, with a ceiling value of $8.41 million for data systems updates, data integration, and computational applications supporting drug discovery and therapeutics development through March 31, 2027. Place of performance is Frederick, Maryland. The order is priced on a cost-plus-fixed-fee basis with no set-aside designation. Service Contract Inventory reporting shows actual government-invoiced...
- The National Cancer Institute issued a delivery order to Social & Scientific Systems, Inc. on September 1, 2023, under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services IDIQ for epidemiology and dosimetry studies of radiation-related cancers, with a ceiling value of $4.84 million. Place of performance is Silver Spring, Maryland. The order extends through August 31, 2028, and is priced on a cost-plus-fixed-fee basis with no set-aside. Service...